Skip to main content
Clinical Trials/JPRN-UMIN000009647
JPRN-UMIN000009647Not yet recruiting未知

Efficacy of treatments for Japanese cedar pollinosis based on guideline -combined treatment ofleukotriene receptor antagonist with H1 receptor antagonists - Combined treatment of LTRA with H1RA

Okayama University0 sites100 target enrollmentStarted: June 1, 2013Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Enrollment
100

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
16years-old to 65years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1) concomitant sinonasal disease that could potentially affect the outcome of the trial (e.g., nasal polyps, rhinosinusitis, nasal septum deviation); (2) concomitant treatment for AR caused by allergens other than Japanese cedar/cypress pollen; (3) rhinitis medicamentosa and non-infectious, non-allergic rhinitis; (4) medication with anti-allergic drugs including H1RA, chromones, glucocorticoids and decongestants within 2 weeks of study initiation; (5) cedar pollen-specific immunotherapy; (6) sinonasal surgery including laser vaporization of inferior turbinates within 6 months;(7) concomittant uncontrolled asthma (8) hypersensitivity to INS and H1RA (9)systemic infection including mycosis; or (10) were pregnant and breastfeeding.

Investigators

Similar Trials